Photrexa
Payments companies reported to CMS as associated with Photrexa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Photrexa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Photrexa
These are the largest totals companies reported as associated with Photrexa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jesse Dovich | Golden Valley, MN | Ophthalmology | $350.00 |
| Richmond Roeske | Upland, CA | Ophthalmology | $350.00 |
| Kunal Merchant | Glen Rock, NJ | Ophthalmology | $320.30 |
| Kathyrn Masselam Hatch | Watham, MA | Ophthalmology | $316.84 |
| John Gelles | Sunnyvale, CA | Corneal and Contact Management | $297.45 |
| Jerome Bouchez | Omaha, NE | Optometrist | $288.54 |
| Irena Sigel | Denver, CO | Optometrist | $288.54 |
| Nandini Venkateswaran | Waltham, MA | Ophthalmology | $272.48 |
| John Cason | Phoenix, AZ | Ophthalmology | $269.29 |
| Eric Donnenfeld | Garden City, NY | Ophthalmology | $260.34 |
Prescribed Photrexa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.